Forty Seven Inc (FTSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FTSV | CRNX | INDV | ||
| Company | Forty Seven Inc | Crinetics Pharmaceuticals Inc | Indivior Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 95.46 | 53.52 | 35.52 | ||
| High | 95.52 | 56.13 | 35.82 | ||
| Low | 95.46 | 53.17 | 33.76 | ||
| Latest | 95.51 | 53.25 | 35.44 | ||
| Change | +0.05 | +0.01 | -0.07 | ||
| % Change | +0.05% | +0.02% | -0.20% | ||
| Volume | 693,900 | 2,230,100 | 2,553,200 | ||
| 20-Day Average Volume | 1,555,145 | 1,603,940 | 3,170,375 | ||
| Previous Close | 95.46 | 53.24 | 35.51 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 93.81 | 48.78 | 35.84 | ||
| 20-Day Raw Stochastic | 99.93% | 68.29% | 43.08% | ||
| 20-Day Relative Strength | 80.98 | 63.66 | 58.81 | ||
| Weighted Alpha | +174.00 | +40.10 | +209.63 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 03/30/20 | +13.95% since 01/02/26 | -0.81% since 01/02/26 | ||
| Low | 95.25 on 04/01/20 | 43.40 on 01/06/26 | 33.76 on 01/09/26 | ||
| High | 95.51 on 04/06/20 | 57.99 on 01/05/26 | 37.66 on 01/08/26 | ||
| 1-Month | |||||
| %Chg | +1.23% since 03/06/20 | +11.17% since 12/09/25 | -1.58% since 12/09/25 | ||
| Low | 88.00 on 03/18/20 | 43.04 on 12/18/25 | 33.76 on 01/09/26 | ||
| High | 95.51 on 04/06/20 | 57.99 on 01/05/26 | 37.66 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | +150.62% since 01/06/20 | +16.37% since 10/09/25 | +46.75% since 10/09/25 | ||
| Low | 32.29 on 01/13/20 | 38.81 on 11/07/25 | 22.95 on 10/10/25 | ||
| High | 95.51 on 04/06/20 | 57.99 on 01/05/26 | 38.00 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +1,481.29% since 10/04/19 | +64.71% since 07/09/25 | +134.08% since 07/09/25 | ||
| Low | 5.53 on 10/23/19 | 25.83 on 08/08/25 | 15.00 on 07/16/25 | ||
| High | 95.51 on 04/06/20 | 57.99 on 01/05/26 | 38.00 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,599,379 | 5,052,999 | 4,430,708 | ||
| Shares Outstanding, K | 48,156 | 94,892 | 125,020 | ||
| Annual Sales | 15,680,000 | 1,040,000 | 1,188,000,000 | ||
| Annual Net Income | -87,620,000 | -298,410,000 | 2,000,000 | ||
| Last Quarter Sales | 0 | 140,000 | 314,000,000 | ||
| Last Quarter Net Income | -26,240,000 | -130,090,000 | 42,000,000 | ||
| 60-Month Beta | 0.40 | 0.20 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.38 on 11/06/25 | 0.72 on 10/30/25 | ||
| Latest Earnings Date | 05/11/20 | 02/26/26 | 02/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 18.08 | ||